ACT

MAR.21/2017


news roundup

CRF Health Releases eConsent Survey Results

According to the results of a new ‘State of eConsent’ survey released by CRF Health, 55% of respondents’ organizations will adopt eConsent in 2017, rising to 82% by 2020.


advertisment

Designed exclusively for Clinical Development, by Clinical Development experts - The industry’s first training and educational portal filled with white papers, thought leadership articles, and much more all at your fingertips!
CTA: Dive into Almac Clinical University
Learn more


Special Session in EU Over Brexit

IAOCR, an accrediting organization for international clinical research, is spearheading an emergency summit to discuss how to safeguard the clinical research industry in the U.K. before and after Brexit. It will take place on Wednesday, April 5th at a venue in the South Bucks/Berkshire area.


advertisment

Clinical Trials, Technology and Transformation
Acquire insights from 70+ influential industry leaders touching on technology innovation, mHealth, patient-centricity, effective collaborations, reducing costs and more at T3: Trials, Tech and Transformation, May 11-12, 2017 in Orlando, FL. Act now as early registration rate deadline is March 17th. Want more incentive? Save an additional $250 off current rate. Use Code: T3ACT.
Click here for further details


Netherlands Company, OmniComm Collaborate

CHDR and OmniComm will collaborate in a new technology evaluation center in Leiden, the Netherlands, where innovative products and electronic data capture (EDC) management systems will be immediately tested in an onsite clinical setting.


advertisment

IRT EUROPE – Interactive Response Technologies in Clinical Trials
4-5 April 2017 | Hilton Paddington | London, England
Leverage IRT to Enable Innovative, Flexible and Efficient Supply Chain Management for Clinical Trials
www.cbinet.com/irteu


Updated for March, Business and People News

The latest updates to people moves and business news.


Take the Clinical Endpoints Adjudication Survey!

The survey will evaluate how endpoint adjudication is impacting study design, and uncover operational challenges with endpoint adjudication and endpoint adjudication outcomes.

advertisment

In this edition

A Look at Gottlieb as New FDA Commissioner
Updated for March, Business and People News
Leveraging Big Data for Site Selection

advertisment

Improving Clinical Trial Transparency, Collaboration and Efficiencies
Live Webinar: Wednesday, March 29 at 11:00am EDT
Register now


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


advertisment

Use Challenge Trials Effectively in Clinical Studies: Lessons Learned from H3N2 Influenza Virus
Live Webinar: Tuesday, March 28 at 3 pm CEST and Thursday, April 6 at 10 am EDT
Register now


Events

Imaging in Clinical Trials
3rd Annual Endpoint Adjudication
4th Annual eSource Data in Clinical Investigations Bootcamp
Search Upcoming Events

advertisment

Are Local IRBs Really Necessary?
On Demand
Learn more


Articles

Utilize the Cloud for Data-Intensive Research

Through economies of scale and mechanisms enabling clients to provision and decommission a variety of virtual computer, storage, and networking resources on demand, these cloud platforms are able to provide an alternative to the traditional data center that can be significantly less expensive.


Leveraging Big Data for Site Selection

Companies that fail to implement predictive modeling solutions that analyze data to determine the probability of achieving their target outcome when making their site selection decisions are at risk of falling behind their industry peers.

Blog Posts

A Look at Gottlieb as New FDA Commissioner

As a former FDA official and resident fellow at the conservative American Enterprise Institute (AEI), who also has strong ties to pharma, Scott Gottlieb was the clear choice of industry, as well as many research and patient groups.


The Financial Case for Moving Away from Manual Processes

Let’s take the conservative view: assuming your organization is conducting 20 or more trials per year, shortening the timeline of each trial in your clinical development pipeline by one week could add up to more than $1 million in savings.


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Mike Tessalone
Publisher
Michael.Tessalone@ubm.com